Vernalis to raise £68.5m 10/02/2012
Drug discoverer Vernalis (VER) is to raise £68.5 million as part of a joint venture with US concern Tris Pharma.
International architect and interior design specialist Aukett Fitzroy Robinson sounds upbeat after cutting first-half losses from £1.2 million to £299,000.
The London-based company saw turnover halve to £4 million in the six months to March, which chief executive officer Nicholas Thompson blames on a slowdown in Russian operations and reduced activity in Middle East commercial markets. But AIM-quoted Aukett managed to cut costs by £3.5 million and reduced net debt by £488,000.
At home, the company turned a £1.8 million UK loss into a £22,000 operating profit in the first six months and enhanced its prestige by winning two awards from the British Council for Offices. Aukett’s Berlin and Frankfurt offices generated a reduced profit of £65,000.
However, the company’s Russian business turned a £595,000 profit into a £342,000 first-half loss as turnover there collapsed from £1.9 million to £181,000, with clients deferring projects or being taken over by their banks. Poland, the Czech Republic and Slovakia produced a combined loss of £72,000, down by £13,000, on turnover 15 per cent lower at £647,000.
In April and May, Aukett recovered £1 million of outstanding debts and says it hopes to receive another £1.2 million once properties on which it has secured charges are sold. Longer term, the company, whose London clients include Land Securities, the Grosvenor estate, GE Capital and Great Portland Estates, suggests an expected recovery in the capital’s commercial rents by 2012 will coincide with demand for the renewal of commercial properties in London.
Aukett shares, which fell from nearly 18p in 2007 to 2.5p within the past year, now stand at 4.13p. That values the company at an undemanding £6 million.
Subscribe today and save 50%. Receive company watch recommendations and extensive company profile tips, released two months ahead of the market.
Advertisement
£100 credit when you open five trades within 60 days – terms apply. Spread Trading is not for everyone please ensure you understand the risks as you may lose more than your initial deposit. Click here for more information.
This unique study analyses the shareholdings of companies listed on AIM, extracting trends including rankings of the value and number of their investments.
Please click here to order your copy of the report or call 0207 250 7056.
Informative features and research on fast-growing companies, small-cap and growth stocks, penny shares, stock market tips and share recommendations, directors' dealings, company news and analysis, new issues and upcoming IPOs.
If you're interested in business tax updates visit our specialist tax guide website.
Daily coverage of small-cap company stocks on London's junior markets AIM and PLUS, breaking news, stock research and latest share price information for investors. Full sector coverage with all the latest news on smaller listed companies, updated several times a day with financial reports, trading statements and links to further web resources.
Advertisement
Drug discoverer Vernalis (VER) is to raise £68.5 million as part of a joint venture with US concern Tris Pharma.
Magnolia Petroleum (MAGP) has acquired 800 acres in the Mississippi Lime formation in Oklahoma.
Gold explorer Condor Resources (CNR) has reported encouraging results from drilling at its La India project in Nicaragua.
US-focused Nighthawk Energy is launching a $7.5 million program to invest in its Colorado-based Jolly Ranch project.
Africa-focused Tower Resources (TRP) has raised £5.4 million via a placing with a mixture of institutional investors and directors.
Beleaguered travel operator Thomas Cook (TCG) has reported a loss of £91 million its first quarter also announcing the sale of its Indian division.